Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta2-microglobulin and amyloidosis.

T B Drüeke1

  • 1INSERM Unit 90 and Department of Nephrology, Hôpital Necker, Paris, France.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|March 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial.

Journal of human hypertension·2015
Same author

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011
Same author

Is parathyroid hormone measurement useful for the diagnosis of renal bone disease?

Kidney international·2008
Same author

Pleiotropic effects of the non-calcium phosphate binder sevelamer.

Kidney international. Supplement·2006
Same author

Pathophysiological aspects of vascular calcification in chronic renal failure.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2005
Same author

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Beyond Diffusion and Convection: Is Adsorption the Third Dimension of Dialysis?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Urinary protein vs albumin for assessing kidney failure risk in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
See all related articles

Dialysis amyloidosis, linked to beta2-microglobulin (beta2-M) buildup in chronic kidney failure, causes joint pain. Advanced dialysis methods may delay its onset, while kidney transplants offer relief.

Area of Science:

  • Nephrology
  • Rheumatology
  • Biochemistry

Background:

  • Dialysis-associated amyloidosis is a severe complication in patients undergoing chronic dialysis.
  • It manifests as joint pain, destructive arthropathies, and carpal tunnel syndrome due to beta2-microglobulin (beta2-M) amyloid deposits.

Purpose of the Study:

  • To explore the pathogenesis of dialysis amyloidosis, focusing on beta2-microglobulin (beta2-M) and associated factors.
  • To evaluate the impact of dialysis strategies and kidney transplantation on the disease.

Main Methods:

  • Review of existing literature on dialysis amyloidosis, beta2-microglobulin (beta2-M) metabolism, and dialysis techniques.
  • Analysis of factors contributing to beta2-M amyloid deposition, including advanced glycation/oxidation products and other compounds.

Related Experiment Videos

Main Results:

  • Elevated plasma beta2-M in chronic renal failure is a key factor, though not fully reducible by dialysis.
  • Multiple systemic and local factors contribute to amyloid formation, potentially including direct tissue effects of beta2-M.
  • High-performance dialysis membranes and ultrapure dialysate may offer partial protection or delay disease onset.

Conclusions:

  • Dialysis amyloidosis pathogenesis is multifactorial, involving beta2-M and other substances.
  • Advanced dialysis techniques may mitigate disease progression.
  • Kidney transplantation generally halts the disease and alleviates symptoms, though amyloid deposits may persist.